SRI shareholders contact board

TAMPA — A pair of investment funds represented by David Wright asked the board of directors at SRI Surgical Express Inc. to form a special committee to consider the firm's growth strategy.

The request is in response to news that the firm had recently attached a “poison pill” contract to shares of its common stock.

After a competitor expressed unsolicited interest in buying the company in November, the board of directors at SRI/Surgical Express Inc. adopted a plan that would ward off hostile takeovers. The plan allows SRI shareholders to buy $30 worth of SRI stock for $15 in the event that an outside buyer obtains 15% of SRI's outstanding shares.